WASHINGTON (AP) -- Three pharmaceutical manufacturers have agreed to pay $421 million to settle allegations that the companies reported inflated prices for numerous products, the Justice Department announced Tuesday.
The government says the companies knew that federal health care programs relied on the inflated prices to set payment rates.
The three companies involved in the settlement are Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc.
The Justice Department has recovered more than $1.8 billion from pharmaceutical companies arising from similar unlawful drug pricing schemes, Assistant Attorney General Tony West told a news conference.
The government says the companies knew that federal health care programs relied on the inflated prices to set payment rates.
The three companies involved in the settlement are Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc.
The Justice Department has recovered more than $1.8 billion from pharmaceutical companies arising from similar unlawful drug pricing schemes, Assistant Attorney General Tony West told a news conference.
